Back to search
FDAFDA · Food and drugs·Recall number D-1871-2019

Fexofenadine HCL Tablets USP, 180 mg, 500's BRITE STOCK; Manufactured for: Aurohealth LLC., 2572 Brunswick Pike, Lawrenceville, NJ 08648; Manufactured by: Aurolife Pharma LLC, Dayton, NJ 08810.

Published September 25, 2019 · Recall initiated: August 23, 2019

Summary

FDA records drug Class II recall D-1871-2019, published September 25, 2019 and initiated August 23, 2019. Recalling firm: Aurolife Pharma, LLC; Status: Terminated; Reported quantity: 6104 bottles; Lot: Lot #s:067180011A, 067180012A, Exp 04/21, 06718027B1, Exp 09/21. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Aurolife Pharma, LLC
Distributor
Nationwide in the USA
Lot
Lot #s:067180011A, 067180012A, Exp 04/21, 06718027B1, Exp 09/21
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fexofenadine HCL Tablets USP, 180 mg, 500's BRITE STOCK; Manufactured for: Aurohealth LLC., 2572 Brunswick Pike, Lawrenceville, NJ 08648; Manufactured by: Aurolife Pharma LLC, Dayton, NJ 08810. recalled?

Yes. FDA published recall D-1871-2019 on September 25, 2019. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter